Toggle Nav
Close
  • Menu
  • Setting

CREKA peptide

Catalog No.
C8594
A short peptide with self-assembly properties
Grouped product items
SizePriceStock Qty
50mg
$200.00
Ship with 15-20 days
100mg
$300.00
Ship with 15-20 days
200mg
$500.00
Ship with 15-20 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

CREKA peptide is a short peptide with self-assembly properties, and its sequence is Cys-Arg-Glu-Lys-Ala (CREKA). This short peptide can achieve targeted localization of the lesion site by specifically recognizing and binding to the overexpressed fibrin in the lesion tissue. Studies have shown that CREKA peptide can effectively target disease areas such as cancer, myocardial ischemia-reperfusion injury and atherosclerosis. Due to its excellent targeting and self-assembly capabilities, CREKA peptide has broad application prospects in the field of nanomedicine technology. It can be used to construct targeted drug delivery systems, diagnostic imaging probes, and therapeutic nanomaterials, and is expected to improve the accuracy and effectiveness of disease diagnosis and treatment.

Chemical Properties

StorageStore at -20°C for 3 years.
M.Wt605.71
Cas No.847058-45-1
FormulaC23H43N9O8S
SolubilitySoluble in DMSO
Chemical Name(6S,9S,12S,15S)-1-amino-6-((R)-2-amino-3-mercaptopropanamido)-12-(4-aminobutyl)-9-(2-carboxyethyl)-1-imino-15-methyl-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid
SDFDownload SDF
Canonical SMILESSC[C@H](N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.